Compare Centene Corp (CNC) vs Dover Corp (DOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Dover Corp — how do they compare? Centene Corp trades at $65.58 (market cap $32.89B), while Dover Corp trades at $208.79 (market cap $28.30B). The key difference: Centene Corp is the larger of the two by market cap, and Dover Corp pays a 0.99% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | DOV | |
|---|---|---|
Market Cap | $32.89B | $28.30B |
Sector | Health | Industrials |
52-Week High | $68.72 | $233.31 |
52-Week Low | $26.17 | $161.16 |
Enterprise Value | $21.93B | $29.80B |
Dividend Yield | — | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene (CNC) trades at $65.77, up 2.48% with a bullish technical signal. Recent Q2 2026 earnings beat expectations with EPS of $2.51 versus $1.09 estimate, driven by margin recovery and cost control. Revenue grew to $194.78B in 2025, though net income was negative at -$6.67B. Valuation ratios are attractive with P/E of 8.06 and P/S of 0.16. Analyst consensus is strongly bullish with 61.37% buy ratings and a $70.36 price target.
Outlook is positive due to raised 2026 guidance and operational improvements, but risks include Medicaid membership softness and persistent negative margins. The stock offers value potential if profitability rebounds as projected, though investors should monitor medical cost trends and regulatory changes affecting government healthcare programs.
Dover Corporation (DOV) trades at $211.13, up 0.14% on the day, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings beat expectations with EPS of $2.74, and the company raised its full-year guidance. A dividend increase to $0.525 per share and the acquisition of Cloeren highlight positive corporate actions. Valuation ratios include a P/E of 25.53 and net income margin of 13.48%, reflecting solid profitability.
The outlook for DOV is positive, driven by earnings momentum, raised guidance, and strategic acquisitions. Risks include exposure to manufacturing cycles and macroeconomic volatility. With 19 buy ratings and a consensus price target of $232.33, Wall Street sees upside potential, though investors should monitor execution on growth initiatives and sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →
